Regorafenib in Combination With Metronomic Chemotherapies, and Low-dose Aspirin in Metastatic Colorectal Cancer

NCT04534218 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Colo-rectal Cancer
Metastatic Cancer

Interventions

DRUG: Regorafenib
DRUG: Cyclophosphamide
DRUG: Capecitabine
DRUG: Aspirin

Sponsor

Centre Hospitalier Universitaire de Besancon

Collaborators

[object Object]